211 related articles for article (PubMed ID: 33781551)
1. COVID19 and acute lymphoblastic leukemias of children and adolescents: Updated recommendations (Version 2) of the Leukemia Committee of the French Society for the fight against Cancers and leukemias in children and adolescents (SFCE).
Rouger-Gaudichon J; Bertrand Y; Boissel N; Brethon B; Ducassou S; Gandemer V; Halfon-Domenech C; Leblanc T; Leverger G; Michel G; Petit A; Ray-Lunven AF; Rohrlich PS; Schneider P; Sirvent N; Strullu M; Baruchel A;
Bull Cancer; 2021 May; 108(5):490-500. PubMed ID: 33781551
[TBL] [Abstract][Full Text] [Related]
2. COVID-19 and acute lymphoblastic leukemias of children and adolescents: First recommendations of the Leukemia committee of the French Society for the fight against Cancers and Leukemias in children and adolescents (SFCE).
Baruchel A; Bertrand Y; Boissel N; Brethon B; Ducassou S; Gandemer V; Halfon-Domenech C; Leblanc T; Leverger G; Michel G; Petit A; Ray-Lunven AF; Rohrlich PS; Schneider P; Sirvent N; Strullu M;
Bull Cancer; 2020 Jun; 107(6):629-632. PubMed ID: 32387061
[TBL] [Abstract][Full Text] [Related]
3. A 10-Year-old Girl With Late Acute Lymphoblastic Leukemia Recurrence Diagnosed With COVID-19 and Treated With Remdesivir.
Gadzińska J; Kuchar E; Matysiak M; Wanke-Rytt M; Kloc M; Kubiak JZ
J Pediatr Hematol Oncol; 2022 Mar; 44(2):e537-e538. PubMed ID: 33885040
[TBL] [Abstract][Full Text] [Related]
4. [Practical management during maintenance therapy of pediatric acute lymphoblastic leukemia: Recommendations of the French Society for Childhood and Adolescent Cancer and Leukemia (SFCE)].
Saultier P; Simonin M; Beaumais TA; Rialland F; Alby-Laurent F; Lubnau M; Desplantes C; Jacqz-Aigrain E; Rohrlich P; Reguerre Y; Rabian F; Sirvent N; Plat GW; Petit A
Bull Cancer; 2022 Nov; 109(11):1132-1143. PubMed ID: 35863954
[TBL] [Abstract][Full Text] [Related]
5. Laboratory divergences in concurrent diagnosis of acute myeloid leukemia relapse and COVID-19: A case report.
Nizet A; Foguenne J; Gothot A; Tassin F; Keutgens A
Int J Lab Hematol; 2021 Oct; 43(5):e264-e265. PubMed ID: 33881804
[No Abstract] [Full Text] [Related]
6. Immune responses and therapeutic challenges in paediatric patients with new-onset acute myeloid leukaemia and concomitant COVID-19.
Patel PA; Lapp SA; Grubbs G; Edara VV; Rostad CA; Stokes CL; Pauly MG; Anderson EJ; Piantadosi A; Suthar MS; Khurana S; Sabnis HS
Br J Haematol; 2021 Aug; 194(3):549-553. PubMed ID: 34096051
[No Abstract] [Full Text] [Related]
7. The 11th Trial of a Cardiovascular Clinical Trialist: Coronavirus-2: Part 5.
Frishman WH
Cardiol Rev; 2021 May-Jun 01; 29(3):109. PubMed ID: 33758124
[No Abstract] [Full Text] [Related]
8. Severe COVID-19 Infections-Knowledge Gained and Remaining Questions.
Bos LDJ; Brodie D; Calfee CS
JAMA Intern Med; 2021 Jan; 181(1):9-11. PubMed ID: 32945833
[No Abstract] [Full Text] [Related]
9. Remdesivir for COVID-19 in Europe: will it provide value for money?
Dal-Ré R; Banzi R; Georgin-Lavialle S; Porcher R; Sofat R; Zeitlinger M; Rosendaal FR
Lancet Respir Med; 2021 Feb; 9(2):127-128. PubMed ID: 33341157
[No Abstract] [Full Text] [Related]
10. The race against COVID-19.
Nat Nanotechnol; 2020 Apr; 15(4):239-240. PubMed ID: 32303704
[No Abstract] [Full Text] [Related]
11. COVID-19 in pediatric cancer patients is associated with treatment interruptions but not with short-term mortality: a Polish national study.
Węcławek-Tompol J; Zakrzewska Z; Gryniewicz-Kwiatkowska O; Pierlejewski F; Bień E; Zaucha-Prażmo A; Zając-Spychała O; Szmydki-Baran A; Mizia-Malarz A; Bal W; Sawicka-Żukowska M; Kruk A; Ociepa T; Raciborska A; Książek A; Szczepański T; Peregud-Pogorzelski J; Krawczuk-Rybak M; Chaber R; Matysiak M; Wachowiak J; Irga-Jaworska N; Młynarski W; Dembowska-Bagińska B; Balwierz W; Matkowska-Kocjan A; Kazanowska B; Styczyński J; Ussowicz M
J Hematol Oncol; 2021 Oct; 14(1):163. PubMed ID: 34635137
[TBL] [Abstract][Full Text] [Related]
12. A Guide to COVID-19: a global pandemic caused by the novel coronavirus SARS-CoV-2.
Atzrodt CL; Maknojia I; McCarthy RDP; Oldfield TM; Po J; Ta KTL; Stepp HE; Clements TP
FEBS J; 2020 Sep; 287(17):3633-3650. PubMed ID: 32446285
[TBL] [Abstract][Full Text] [Related]
13. [Not Available].
Wu PE; Morris AM
CMAJ; 2021 Apr; 193(14):E495-E496. PubMed ID: 33824151
[No Abstract] [Full Text] [Related]
14. The Era of the Coronavirus Disease 2019 Pandemic: A Review on Dynamics, Clinical Symptoms and Complications, Diagnosis, and Treatment.
Younis NK; Zareef RO; Maktabi MAN; Mahfouz R
Genet Test Mol Biomarkers; 2021 Feb; 25(2):85-101. PubMed ID: 33596144
[TBL] [Abstract][Full Text] [Related]
15. Update Alert 2: Remdesivir for Adults With COVID-19.
Kaka AS; MacDonald R; Linskens EJ; Wilt TJ
Ann Intern Med; 2021 Dec; 174(12):W114-W115. PubMed ID: 34606312
[No Abstract] [Full Text] [Related]
16. [Long-term destiny of adolescents and young adults with de novo acute lymphoblastic leukemia treated with a pediatric protocol type].
López-Hernández MA; Alvarado-Ibarra M; Álvarez-Veral JL; Ortiz-Zepeda M; Guajardo-Leal ML; Cota-Range X
Gac Med Mex; 2016; 152(5):439-443. PubMed ID: 27792701
[TBL] [Abstract][Full Text] [Related]
17. What Do We Know About Remdesivir Drug Interactions?
Yang K
Clin Transl Sci; 2020 Sep; 13(5):842-844. PubMed ID: 32402130
[No Abstract] [Full Text] [Related]
18. Experts Discuss COVID-19-Remdesivir, Vaccines, and More.
JAMA; 2020 Aug; 324(8):730-731. PubMed ID: 32777002
[No Abstract] [Full Text] [Related]
19. Treatment of childhood leukemias.
Pui CH; Crist WM
Curr Opin Oncol; 1995 Jan; 7(1):36-44. PubMed ID: 7696362
[TBL] [Abstract][Full Text] [Related]
20. Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2).
Qaseem A; Yost J; Etxeandia-Ikobaltzeta I; Abraham GM; Jokela JA; Forciea MA; Miller MC; Humphrey LL; ; Centor RM; Andrews R; Haeme R
Ann Intern Med; 2021 May; 174(5):673-679. PubMed ID: 33560862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
